Reported shares: side effects 36 percent, logistical challenges 24 percent, cost 23 percent, supply shortages 11 percent, dissatisfaction with weight loss 7 percent
Healthcare providers should demonstrate correct technique and monitor site reactions during treatment initiation
For tirzepatide, CVOTs are still not published
This species belongs to the Elapidae family, a group of snakes known for potent neurotoxic venom and fixed front fangs
the medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
At an annual cost of ~17K, this once-weekly injection offers a convenient option for adults with obesity (BMI 30) or those who are overweight (BMI 27) with related health conditions, helping them achieve and maintain weight loss